ArticleBlood advances2019
Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab.
Catherine Lai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleBlood advances2019
Catherine Lai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.